Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Marrow hyperplasia
ADR ID BADD_A02665
ADR Hierarchy
01      Blood and lymphatic system disorders
01.13      Haematopoietic neoplasms (excl leukaemias and lymphomas)
01.13.01      Haematologic neoplasms NEC
01.13.01.001      Marrow hyperplasia
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.21      Haematopoietic neoplasms (excl leukaemias and lymphomas)
16.21.01      Haematologic neoplasms NEC
16.21.01.001      Marrow hyperplasia
Description Not Available
MedDRA Code 10026851
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Haematopoiesis increased | Hematopoiesis increased | Hyperplasia bone marrow | Hyperplasia erythroid | Marrow hypercellular | Marrow hyperplasia | Marrow hyperplasia of | Panmyelosis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00194Azacitidine0.000112%
BADD_D00788Epoprostenol0.000082%
BADD_D00809Escitalopram--
BADD_D01136Imatinib0.000280%
BADD_D01243Lamotrigine0.000083%
BADD_D01245Lansoprazole0.000298%
BADD_D01507Mycophenolate mofetil--
BADD_D01567Nilotinib0.000168%
BADD_D01834Prednisone0.000009%
BADD_D01880Pyrazinamide--
BADD_D01909Ramipril0.000186%
BADD_D01978Ruxolitinib0.000137%
BADD_D02524Ivosidenib0.000112%
The 1th Page    1    Total 1 Pages